Abstract

The Master Agreement Holder (MA holder) will develop and conduct a Phase Ib clinical trial to study the combination of a monoclonal antibody with an interferon or IL-2, with or without adoptive transfer of cells capable of mediating ADCC, for the treatment of cancer.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM047675-001010
Application #
3612203
Study Section
Project Start
1987-09-30
Project End
Budget Start
1991-09-05
Budget End
1992-08-31
Support Year
Fiscal Year
1991
Total Cost
Indirect Cost

  Institution

Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089